News

All | 2022 | 2021 | 2020 | 2019

In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors. All women do not carry the same risk for the same type... Read More

POSTED: 05/06/2022
SOURCE: Cancer Prevention Science Blog

Established Risk Factors for Developing Female Breast Cancer

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page The... Read More

POSTED: 04/28/2022
SOURCE: DCP News

ULACNet-301 participant receiving first study vaccine.

Screening for Many Cancers with One Test: Uncertainty Abounds

One of the exciting areas of cancer prevention research is the development of noninvasive tests that may have the potential to easily and accurately determine whether and where in the body a person has early-stage cancer.... Read More

POSTED: 04/21/2022
SOURCE: NCI Cancer Currents Blog

Illustration of biomarkers that are released by cancer cells or induced by their presence.

Can Cancer Blood Tests Live Up to Promise of Saving Lives?

Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET... Read More

POSTED: 04/11/2022
SOURCE: AP News

April 8-13, 2022 DCP/PREVENT-funded Project Presentations Session OPO.IM01.01 - Tumor Immunobiology 5631 - Immunomodulatory activity of sulindac plus erlotinib for colon cancer prevention in familial adenomatous... Read More

POSTED: 04/01/2022
SOURCE: DCP News

AACR Annual Meeting 2022

CP-CTNet Newsletter - March 2022

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet). Read More

POSTED: 03/31/2022
SOURCE: CP-CTNet DMACC Website

Screen capture of the cover of CP-CTNet March 2022 Newsletter.

Press Release: Enrollment in TMIST Breast Cancer Screening Trial Surpasses Halfway Mark; Recruitment of Women from Diverse Backgrounds is Key to Success

Philadelphia, March 25, 2022 — The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), is more than halfway to its recruiting goal of 128,905 participants with more than 20% of participants in the United States being... Read More

POSTED: 03/25/2022
SOURCE: ECOG-ACRIN Press Release

A group of women from diverse backgrounds.

RESEARCH UPDATE: ON THE CLINICAL FRONT Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Colon Adenoma Patients Preclinical studies suggest calcium, vitamin D, and vitamin D... Read More

POSTED: 03/18/2022
SOURCE: DCP News

An image of foods high in calcium, vitamin D, and vitamin D receptors.

Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat... Read More

POSTED: 02/09/2022
SOURCE: Cancer Prevention Science Blog

An illustration displaying signal amplification.

Study Identifies Potential Drug Target to Prevent Some Liver Cancers

While new cases of most cancer types have dropped over the past decade, cases of the most common type of liver cancer, hepatocellular carcinoma (HCC), are on the rise. Until recently, the main cause of HCC was hepatitis C... Read More

POSTED: 02/04/2022
SOURCE: NCI Cancer Currents Blog

Illustration showing progression from normal liver to nonalcoholic steatohepatitis.

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page... Read More

POSTED: 01/28/2022
SOURCE: DCP News

Partial screen grab of the ULACNet Zoom meeting showing a grid 9 participants.

Even If Insured, People with Advanced Cancer Often Face Financial Problems

Many people being treated for advanced cancer experience serious financial problems related to the cost of their care, even if they have health insurance, according to a new study. Read More

POSTED: 01/26/2022
SOURCE: NCI Cancer Currents Blog

Photo of a health insurance statement.

Key Messages There are many screening questions that can be addressed through clinical trials. One size doesn’t fit all: There is a trend for increasingly personalized screening, where cancer screening recommendations are... Read More

POSTED: 01/25/2022
SOURCE: DCP News

A meeting of statistical leads from the seven NCI Community Oncology Research Program (NCORP) Research Bases with statisticians from the Division of Cancer Prevention (DCP) Biometry Research Group took place on July 16, 2021... Read More

POSTED: 01/20/2022
SOURCE: DCP News

Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited. In the United States, almost 60% of people... Read More

POSTED: 01/14/2022
SOURCE: Cancer Prevention Science Blog

An illustration of a displaying a bronchoscopy, entering via nasal swabs to detect a suspicious nodule.

CP-CTNet Newsletter - December 2021

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet). Read More

POSTED: 12/22/2021
SOURCE: CP-CTNet DMACC Website

Partial screen grab of the December 2021 issue of the CP-CTNet Newsletter.

Fifty years ago this week, the National Cancer Act was signed into law, kick-starting research that has changed how cancer is prevented, detected, diagnosed, treated, and survived, and moving us closer to a time when no one... Read More

POSTED: 12/20/2021
SOURCE: Cancer Prevention Science Blog

Thank You--50th Anniversary of the National Cancer Act

For Older Adults, Geriatric Assessment Reduces Cancer Treatment Side Effects

For older adults undergoing treatment for advanced cancer, results from a clinical trial show that a health measurement tool called a geriatric assessment can be an important part of treatment planning. In the trial, older... Read More

POSTED: 12/15/2021
SOURCE: NCI Cancer Currents Blog

An older woman with a handful of oral medications.

RESEARCH UPDATE: ON THE CLINICAL FRONT Diet Quality and Risk and Severity of COVID-19 Evidence for the influence of diet on COVID-19 risk and severity is limited, despite unhealthy lifestyle factors and poor metabolic... Read More

POSTED: 12/01/2021
SOURCE: DCP News

Drawings of COVID-19 cells.

If your family member had cancer, would you want to know if you carried a gene mutation that increased your risk of the same cancer? This question is at the heart of three novel research projects underway to determine how... Read More

POSTED: 11/29/2021
SOURCE: Cancer Prevention Science Blog

An illustration displaying possible inherited risk carriers within a family.

The NCI Community Oncology Research Program (NCORP) annual meeting for grantees in August 2021 virtually brought together representatives from every NCORP Research Base and Community and Minority Underserved Site to discuss... Read More

POSTED: 11/10/2021
SOURCE: Cancer Prevention Science Blog

Drs. McCaskill-Stevens, Underwood, and Adams-Campbell

CP-CTNet Newsletter - September 2021

The first day of autumn was September 22nd. Fall reminds us that change can be a beautiful process. It’s the season that conjures up memories of heading back to school, visits to the pumpkin patch, jumping in piles of... Read More

POSTED: 10/12/2021
SOURCE: CP-CTNet DMACC Website

Screen capture of the Fall 2021 issue the CP-CTNet Newsletter.

In a clinical study underway, scientists hope to unravel the complexities of a group of poorly understood and relatively rare blood disorders that often lead to cancer. In myelodysplastic syndromes (MDS), the problem arises... Read More

POSTED: 10/05/2021
SOURCE: Cancer Prevention Science Blog

Estimated cases of myelodysplastic syndrome cases in the US each year.

A year ago, I said that coming on board as the Division of Cancer Prevention Director in July 2020 was a “challenge,” adding that I had faith in science that the pandemic would be solved soon. Science has brought us a... Read More

POSTED: 09/20/2021
SOURCE: DCP News

 NCI Division of Cancer Prevention: Precision Prevention, Biomarkers of Risk and Early Detection, Symptom Management

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page ULACNet-101... Read More

POSTED: 09/20/2021
SOURCE: DCP News

Group photo of CAMPO team.

Pages